Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 250.69 -3.15 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.84 | 52 Week High | $333.65 | |||
| Open | $251.68 | 52 Week Low | $223.02 | |||
| Day High | $252.44 | P/E | 32.10 | |||
| Day Low | $246.15 | EPS | $7.81 | |||
| Volume | 1,157,339 | |||||



